Monique Steijaert

CHOP Compared With CHOP Plus Granulocyte Colony-Stimulating Factor in Elderly Patients With Aggressive Non-Hodgkin’s Lymphoma

Jeanette K. Doorduijn, Bronno van der Holt, Gustaaf W. van Imhoff et al. · Journal of Clinical Oncology · 2003 · 168 citations

Overall and event-free survival are not improved by the use of myeloablative therapy following intensified chemotherapy in previously untreated patients with multiple myeloma: a prospective randomized phase 3 study

Christine M. Segeren, Pieter Sonneveld, Bronno van der Holt et al. · Blood · 2003 · 163 citations · Full text

Partially T-Cell–Depleted Allogeneic Stem-Cell Transplantation for First-Line Treatment of Multiple Myeloma: A Prospective Evaluation of Patients Treated in the Phase III Study HOVON 24 MM

Henk M. Lokhorst, Christine M. Segeren, Leo F. Verdonck et al. · Journal of Clinical Oncology · 2003 · 79 citations

Abnormalities of chromosome 1p/q are highly associated with chromosome 13/13q deletions and are an adverse prognostic factor for the outcome of high‐dose chemotherapy in patients with multiple myeloma

Ka Lung Wu, Berna Beverloo, Henk M. Lokhorst et al. · British Journal of Haematology · 2007 · 73 citations

Self‐reported quality of life in elderly patients with aggressive non‐Hodgkin's lymphoma treated with CHOP chemotherapy

Jeanette K. Doorduijn, Ivonne Buijt, Bronno van der Holt et al. · European Journal Of Haematology · 2005 · 67 citations